Cialis overtakes Viagra as market leader

Viagra has finally been knocked off its No.1 position in the global market for erectile dysfunction medication by Cialis. In March Viagra claimed about 39% of the market whilst Cialis captured 41% according to IMS Health data. This is a historical “first” and a remarkable milestone for the makers of Cialis, Eli Lilly, considering that Pfizer created the market for erectile dysfunction drugs when they first produced Viagra back in the late 1990s.

The worldwide sales of Cialis totalled $1.7 billion in 2010, representing an increase of 9 percent on the previous year. This included sales outside the USA of over $1 billion.

The differences between Viagra and Cialis may be the reason why Cialis has eventually caught up with and now overtaken Viagra’s market share. With Viagra the user takes it when they need it and the effect wears off after 4 hours. However, with Cialis there are a few more options. The stronger dosages of 10mg and 20mg have an effect which lasts for 36 hours. In France it is know as “le weekender” since its user can take one tablet which lasts the whole weekend. Alternatively, the lower dosages of 2.5mg and 5mg are meant for daily use giving users a better chance of reducing the potential side effects that may occur with regular Cialis 10mg or 20mg tablets.

It is possible that Cialis holds a psychological advantage over Viagra since it is a pill that is either taken once and lasts for a longer period of time (le weekender) or is taken on a daily basis and thus becomes seen as something akin to brushing your teeth in the morning. Either way the theory is that it does not remind the user of their failings whenever they have sex.

Another more tangible theory is that Viagra’s sales are increasingly being eroded by competition from cheap generic copies – a trend that is likely to be exacerbated when their patent on Viagra expires in March 2012. Some analysts believe this may also erode sales of Cialis with Morgan Stanley analyst David Risinger predicting Cialis sales in 2015 of just $1.4 billion.

However, City analyst John Boris predicts Cialis sales in 2015 of $2.2 billion. This scenario is based on the fact that Cialis could maintain a higher price than Viagra because the generics will not have the extended time effect of Cialis. This is because the patent on Cialis will not expire until 2017.

Furthermore, Eli Lilly is coming up with more innovative ideas to keep Cialis sales rising. In Europe they are pushing Cialis as a medication for hypertension, whilst in the U.S. they are currently seeking approval for it to be used as a treatment for middle-aged men with enlarged prostates.

Related Posts - MSC News

  • July 16, 2012 -- Counterfeit Viagra found during routine checks of Chinese adult stores
    A random spot-check  of local adult shops in China by Food and Drug Administration (FDA) inspectors, has uncovered many pills that were being marketed and sold as genuine Viagra tablets. Working toget...
  • VivusMay 1, 2012 -- Viagra Faces STIFF Competition
    The World’s best selling Erectile Dysfunction drug Viagra, may have to face STIFF competition soon as Vivus Inc wins approval for Avanafil, which is a faster acting rival to Viagra....
  • July 6, 2012 -- New drug Zertane-ED on the horizon to treat both ED and PE in men
    Erectile dysfunction is one of the most frustrating conditions for a male to suffer from and it is estimated that 4 in 10 men have impotence problems. The inability to achieve and sustain an erection ...
  • tadalafilNovember 28, 2017 -- Generic Cialis Now Available at Medical Specialists® Pharmacy!
    Medical Specialists® Pharmacy are delighted to announce we now stock Generic Cialis, also known as Tadalafil/Generic Tadalafil, saving patients a huge amount of money in the process! Along with Gen...
  • Pfizer to lose Viagra UK patent in 2012April 12, 2011 -- Pfizer to lose Viagra UK patent in 2012
    Pfizer is gearing up to lose its patent on the famous blue pill, Viagra, in 2012. The development of Viagra Jet will not extend the drug's patent life beyond its 2012 expiration, Pfizer said. A num...
  • Man jailed for 16 weeks for selling dangerous ‘herbal’ male impotence drugAugust 19, 2014 -- Man jailed for 16 weeks for selling dangerous ‘herbal’ male impotence drug
    On Friday a 58-year-old man was slapped with a 16 week prison sentence at Wood Green Crown Court for selling an unlicensed and dangerously potent erectile dysfunction (ED) drug which contained more th...
  • January 4, 2013 -- Cialis: No longer just Viagra’s little brother
    If you are one of the many millions of men around the world suffering from male impotence, known as ‘erectile dysfunction’, your first ‘port of call’ for an effective treatment option may possibly be ...
  • September 14, 2012 -- New erectile dysfunction drug in the pipeline
    Apricus Biosciences Inc. has entered into an exclusive license agreement with Takeda Pharmaceuticals International, to market Vitaros, a treatment for erectile dysfunction in the UK. The marketing aut...
This entry was posted in Cialis, Men's Health, Viagra and tagged , , . Bookmark the permalink.

Comments are closed.